Aytu BioPharma (AYTU) Competitors

Exicure (NASDAQ:XCUR) and Aytu BioPharma (NASDAQ:AYTU) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Does the media refer more to XCUR or AYTU?

In the previous week, Exicure had 2 more articles in the media than Aytu BioPharma. MarketBeat recorded 2 mentions for Exicure and 0 mentions for Aytu BioPharma. Exicure's average media sentiment score of 0.28 beat Aytu BioPharma's score of 0.00 indicating that Exicure is being referred to more favorably in the media.

Company	Overall Sentiment
Exicure	Neutral
Aytu BioPharma	Neutral

Do insiders & institutionals hold more shares of XCUR or AYTU?

42.8% of Exicure shares are held by institutional investors. Comparatively, 33.5% of Aytu BioPharma shares are held by institutional investors. 3.9% of Exicure shares are held by company insiders. Comparatively, 2.8% of Aytu BioPharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer XCUR or AYTU?

Aytu BioPharma received 246 more outperform votes than Exicure when rated by MarketBeat users. Likewise, 67.11% of users gave Aytu BioPharma an outperform vote while only 47.37% of users gave Exicure an outperform vote.

Company	Underperform	Outperform
Exicure	Outperform Votes 9 47.37%	Underperform Votes 10 52.63%
Aytu BioPharma	Outperform Votes 255 67.11%	Underperform Votes 125 32.89%

Which has preferable earnings & valuation, XCUR or AYTU?

Aytu BioPharma has higher revenue and earnings than Exicure. Exicure is trading at a lower price-to-earnings ratio than Aytu BioPharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exicure	$500K	79.84	-$16.91M	-$2.07	-8.88
Aytu BioPharma	$81M	0.12	-$15.84M	-$1.23	-1.33

Which has more volatility & risk, XCUR or AYTU?

Exicure has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Aytu BioPharma has a beta of -1.4, meaning that its stock price is 240% less volatile than the S&P 500.

Is XCUR or AYTU more profitable?

Exicure has a net margin of 0.00% compared to Aytu BioPharma's net margin of -8.28%. Aytu BioPharma's return on equity of -21.89% beat Exicure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exicure	N/A	-190.90%	-36.75%
Aytu BioPharma	-8.28%	-21.89%	-5.37%

Summary

Aytu BioPharma beats Exicure on 8 of the 15 factors compared between the two stocks.